You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

18 Results
Guidelines and Advice
Status: Archived
ID: 17-5
Jul 2016
Guidelines and Advice
Status: In-Review
ID: SCT 6
Feb 2016
Guidelines and Advice
Status: Current
ID: GL-C50-26
Feb 2016
Guidelines and Advice
Status: In-Review
ID: 12-9
Jan 2016
Guidelines and Advice
Status: Archived
ID: 12-16
Jun 2016
Guidelines and Advice
Status: Current
ID: 8-7
Version: 2
Mar 2023
Cancer facts
Jun 2016
Cancer facts
Apr 2016
Drug
Other Name(s): Nexavar®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jul 2023
Drug
Other Name(s): Sutent®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Sep 2023
Regimen
Cancer Type:
Gastrointestinal, 
Hepatobiliary / Liver / Bile Duct
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    SORAfenib - Advanced hepatocellular carcinoma, with specific criteria
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
SORAfenib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Mar 2023
Statistical Reports
Jun 2016

Pages